Medmxr

Medication administration should be simple. However, many patients with congenital adrenal hyperplasia, diabetes, and other diseases need to mix the separate powder and liquid components of their medication right before injection, a process that is difficult and can lead to lethal consequences if performed incorrectly. At MedMxr, we have designed “the EpiPen of multi-component drugs,” an autoinjector that separates drug components until time of use, mixes the components, and injects the medication safely. Our device simplifies the delivery of multi-component medications, thus reducing the risk of error, improving patient adherence, and most importantly, giving patients peace of mind. MedMxr, Inc.(C-Corp) CTIP Portfolio Member since November, 2021: Collaborators: Children's Hospital Los Angeles (CHLA) Minnesota HealthSolutions (MinnHealth) Awards & Recognitions: Baylor New Venture Competition 2022-2023 (in progress): Top 50 Company University Startup World Cup (Venture Cup) 2022: Finalist Maseeh Entrepreneurship Prize Competition (MEPC) 2019-2020: 4th place